PharmaMar Withdraws EU Aplidin Filing After Regulatory Rollercoaster

 
• By Eliza Slawther
  
PharmaMar, Norgine and Philogen have withrawn their EU MAAs for their respective cancer drugs (Shutterstock)

More from EU CHMP

More from United Kingdom